231 related articles for article (PubMed ID: 29975347)
1. Systemic Depletion of Nerve Growth Factor Inhibits Disease Progression in a Genetically Engineered Model of Pancreatic Ductal Adenocarcinoma.
Saloman JL; Singhi AD; Hartman DJ; Normolle DP; Albers KM; Davis BM
Pancreas; 2018 Aug; 47(7):856-863. PubMed ID: 29975347
[TBL] [Abstract][Full Text] [Related]
2. The neurotrophin-trk receptor axes are critical for the growth and progression of human prostatic carcinoma and pancreatic ductal adenocarcinoma xenografts in nude mice.
Miknyoczki SJ; Wan W; Chang H; Dobrzanski P; Ruggeri BA; Dionne CA; Buchkovich K
Clin Cancer Res; 2002 Jun; 8(6):1924-31. PubMed ID: 12060637
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of nerve growth factor antibody in a knee osteoarthritis pain model in mice.
Miyagi M; Ishikawa T; Kamoda H; Suzuki M; Inoue G; Sakuma Y; Oikawa Y; Orita S; Uchida K; Takahashi K; Takaso M; Ohtori S
BMC Musculoskelet Disord; 2017 Nov; 18(1):428. PubMed ID: 29100502
[TBL] [Abstract][Full Text] [Related]
4. [The expression and significance of nerve growth factor and its receptors in pancreatic ductal adenocarcinoma].
Meng LX; Ding ZJ; Chen XP; Fei LS; Chi YH; Zhao ZG; Wang XF; Hao XS
Zhonghua Nei Ke Za Zhi; 2009 Jul; 48(7):562-5. PubMed ID: 19957796
[TBL] [Abstract][Full Text] [Related]
5. Expression of nerve growth factor receptors is correlated with progression and prognosis of human pancreatic cancer.
Dang C; Zhang Y; Ma Q; Shimahara Y
J Gastroenterol Hepatol; 2006 May; 21(5):850-8. PubMed ID: 16704535
[TBL] [Abstract][Full Text] [Related]
6. Nerve growth factor expression correlates with perineural invasion and pain in human pancreatic cancer.
Zhu Z; Friess H; diMola FF; Zimmermann A; Graber HU; Korc M; Büchler MW
J Clin Oncol; 1999 Aug; 17(8):2419-28. PubMed ID: 10561305
[TBL] [Abstract][Full Text] [Related]
7. NGF and GDNF differentially regulate TRPV1 expression that contributes to development of inflammatory thermal hyperalgesia.
Amaya F; Shimosato G; Nagano M; Ueda M; Hashimoto S; Tanaka Y; Suzuki H; Tanaka M
Eur J Neurosci; 2004 Nov; 20(9):2303-10. PubMed ID: 15525272
[TBL] [Abstract][Full Text] [Related]
8. The effect of neutralization of nerve growth factor (NGF) on bladder and urethral dysfunction in mice with spinal cord injury.
Wada N; Shimizu T; Shimizu N; de Groat WC; Kanai AJ; Tyagi P; Kakizaki H; Yoshimura N
Neurourol Urodyn; 2018 Aug; 37(6):1889-1896. PubMed ID: 29516546
[TBL] [Abstract][Full Text] [Related]
9. Blocking Nerve Growth Factor Signaling Reduces the Neural Invasion Potential of Pancreatic Cancer Cells.
Bapat AA; Munoz RM; Von Hoff DD; Han H
PLoS One; 2016; 11(10):e0165586. PubMed ID: 27792755
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of anti-nerve growth factor therapy for discogenic neck pain in rats.
Sainoh T; Sakuma Y; Miyagi M; Orita S; Yamauchi K; Inoue G; Kamoda H; Ishikawa T; Suzuki M; Kubota G; Oikawa Y; Inage K; Sato J; Nakamura J; Aoki Y; Takaso M; Toyone T; Takahashi K; Ohtori S
Spine (Phila Pa 1976); 2014 Jun; 39(13):E757-62. PubMed ID: 24732837
[TBL] [Abstract][Full Text] [Related]
11. Neotrofin, a novel purine that induces NGF-dependent nociceptive nerve sprouting but not hyperalgesia in adult rat skin.
Holmes M; Maysinger D; Foerster A; Pertens E; Barlas C; Diamond J
Mol Cell Neurosci; 2003 Nov; 24(3):568-80. PubMed ID: 14664808
[TBL] [Abstract][Full Text] [Related]
12. Nerve growth factor treatment increases brain-derived neurotrophic factor selectively in TrkA-expressing dorsal root ganglion cells and in their central terminations within the spinal cord.
Michael GJ; Averill S; Nitkunan A; Rattray M; Bennett DL; Yan Q; Priestley JV
J Neurosci; 1997 Nov; 17(21):8476-90. PubMed ID: 9334420
[TBL] [Abstract][Full Text] [Related]
13. Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells.
Zhu ZW; Friess H; Wang L; Bogardus T; Korc M; Kleeff J; Büchler MW
Clin Cancer Res; 2001 Jan; 7(1):105-12. PubMed ID: 11205897
[TBL] [Abstract][Full Text] [Related]
14. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of bradykinin B2 receptor expression by neurotrophic factors and nerve injury in mouse sensory neurons.
Lee YJ; Zachrisson O; Tonge DA; McNaughton PA
Mol Cell Neurosci; 2002 Feb; 19(2):186-200. PubMed ID: 11860272
[TBL] [Abstract][Full Text] [Related]
16. Effect of administration of antibodies against nerve growth factor in a rat model of muscle injury.
Suzuki M; Inage K; Sakuma Y; Orita S; Yamauchi K; Suzuki T; Suzuki M; Kubota G; Oikawa Y; Sainoh T; Sato J; Fujimoto K; Shiga Y; Abe K; Kanamoto H; Takahashi K; Ohtori S
Injury; 2016 Mar; 47(3):609-12. PubMed ID: 26653267
[TBL] [Abstract][Full Text] [Related]
17. Expression of nerve growth factor receptors and their prognostic value in human pancreatic cancer.
Zhang Y; Dang C; Ma Q; Shimahara Y
Oncol Rep; 2005 Jul; 14(1):161-71. PubMed ID: 15944784
[TBL] [Abstract][Full Text] [Related]
18. Reverse transcription-PCR analysis of laser-captured cells points to potential paracrine and autocrine actions of neurotrophins in pancreatic cancer.
Ketterer K; Rao S; Friess H; Weiss J; Büchler MW; Korc M
Clin Cancer Res; 2003 Nov; 9(14):5127-36. PubMed ID: 14613990
[TBL] [Abstract][Full Text] [Related]
19. Effect of anti-nerve growth factor treatment on pituitary adenylate cyclase activating polypeptide expression in adult sensory neurons exposed to adjuvant induced inflammation.
Jongsma Wallin H; Pettersson LM; Verge VM; Danielsen N
Neuroscience; 2003; 120(2):325-31. PubMed ID: 12890505
[TBL] [Abstract][Full Text] [Related]
20. [Relation of nerve growth factor expression with perineural invasion and pain in pancreatic cancer].
Hua ZM; Li Z; Lou DL
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1251-3. PubMed ID: 16939930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]